- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: 3 mg PF-06412562
Total 811 results
-
PfizerCompleted
-
Yale UniversityNational Institute of Mental Health (NIMH); University of Pennsylvania; Columbia... and other collaboratorsActive, not recruitingEarly Course Schizophrenia Spectrum DisorderUnited States
-
PfizerTerminated
-
PfizerCompletedSchizophreniaUnited States
-
University of ZurichPfizerCompletedDecision MakingSwitzerland
-
PfizerCompletedParkinson's DiseaseUnited States
-
InvicroCompletedHealthy Male VolunteersUnited States
-
PfizerCompleted
-
PfizerCompletedAlzheimer's DiseaseKorea, Republic of, Canada, United States, Australia, United Kingdom, Belgium
-
PfizerCompletedAlzheimer's DiseaseUnited States
-
PfizerTerminatedParkinson DiseaseUnited States, Spain, Canada, France, Japan, Germany
-
PfizerTerminatedParkinson's Disease With Motor FluctuationsUnited States
-
PfizerCompleted
-
PfizerCompletedHealthy VolunteersUnited States
-
PfizerCompleted
-
PfizerTerminatedMultiple SclerosisUnited States
-
PfizerWithdrawnUlcerative ColitisUnited States
-
PfizerCompletedDiabetes Melliuts, Type 2United States
-
PfizerCompletedDiabetes Mellitus, Type 2United States, Colombia, Spain, Germany, Sweden, Italy
-
Hoffmann-La RochePfizerCompletedModerate to Severe Ulcerative ColitisUnited States, Australia, Thailand, Poland, Russian Federation, Japan, Colombia, Spain, Turkey, Romania, India, Slovakia, France, Hungary, South Africa, Belgium, Bulgaria, Germany, Italy, Mexico, Serbia, Ukraine, United Kingdom
-
PfizerCompletedHealthy VolunteerNetherlands
-
PfizerCompleted
-
Quark PharmaceuticalsPfizerCompletedAge Related Macular DegenerationSpain, Korea, Republic of, Turkey, Taiwan, United States, Israel, Austria, Philippines, Denmark, Hong Kong, India
-
PfizerCompletedObesity | OverweightUnited States
-
PfizerCompleted
-
PfizerCompleted
-
PfizerCompletedHepatic Impairment | Healthy ParticipantsUnited States
-
PfizerActive, not recruitingHealthy ParticipantsUnited States
-
PfizerCompletedSystemic Lupus ErythematosusSpain, United States, Taiwan, Belgium, Czechia, Japan, Hungary, Germany, United Kingdom, China, France, Australia, Bulgaria, Hong Kong, Korea, Republic of, Colombia, Argentina, Canada, Greece, Italy, Mexico, Poland, Portugal, Romania, S... and more
-
PfizerCompletedHealthy ParticipantsBelgium
-
PfizerCompletedHealthy | Diabetes Mellitus, Type 2 | Renal ImpairmentUnited States
-
PfizerCompletedAlzheimer's DiseaseSweden
-
PfizerCompletedDiabetes Mellitus, Type 2United States, Taiwan, Slovakia, Mexico, Canada, Hungary
-
PfizerCompletedObesityUnited States, Taiwan, Canada, Japan
-
PfizerCompletedAlopecia AreataChina, United States, Spain, Korea, Republic of, Taiwan, Canada, Australia, Germany, Czechia, Poland, Hungary, Japan, United Kingdom, Argentina, Chile, Colombia, Mexico, Russian Federation
-
PfizerTerminatedType 2 Diabetes Mellitus (T2DM)United States
-
PfizerWithdrawnDementia | Alzheimer's Disease | Dimebon | Investigational Drug
-
PfizerTerminated
-
PfizerCompletedDiabetes Mellitus, Type 2Canada, United States, Korea, Republic of, Puerto Rico
-
PfizerCompleted
-
PfizerCompletedDiabetes Mellitus, Type 2Taiwan, United States, Hungary, Canada, Slovakia, India, Bulgaria